skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Ferumoxsil Oral Suspension (Code C62485)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Ferumoxsil Oral Suspension

Definition: An orally administered aqueous suspension of silicone-coated, superparamagnetic iron oxide used as a magnetic resonance imaging (MRI) contrast agent. After oral administration, ferumoxsil fills the stomach and intestines. Upon exposure to the strong external magnetic field during MRI, ferumoxsil exhibits strong T1 relaxation properties and a strongly varying local magnetic field; T2 relaxation is enhanced, thereby darkening the contrast agent-containing portion of the gastrointestinal tract. Delineation of the bowel is thus enhanced, distinguishing bowel from organs and tissues adjacent to the upper regions of the gastrointestinal tract.

Label: Ferumoxsil Oral Suspension

NCI Thesaurus Code: C62485 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0257928  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Ferumoxsil Oral Suspension

External Source Codes: 
PDQ Closed Trial Search ID 489463
PDQ Open Trial Search ID 489463 (check for NCI PDQ open clinical trial info)
UMLS CUI C0257928

Other Properties:
     Name Value (qualifiers indented underneath)
code C62485
Legacy_Concept_Name Ferumoxsil
Semantic_Type Indicator, Reagent, or Diagnostic Aid

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom